ACUTE ISCHEMIC STROKE
IN CHILDREN
A BRIEF OVERVIEW
Tammy Hennika, M.D.
CHILDHOOD STROKE ACTIVATIONS
What
neuroimaging?
What labs?
What is the treatment?
Can we give tPA?
If not a stroke, what could it be?
If it is a stroke, what is the prognosis?
Will it reoccur?
ARTERIAL ISCHEMIC STROKE (AIS)
More common in adults
Also occurs in neonates, infants, children,
and young adults
Result in significant morbidity and
mortality
Incidence 0.6 to 7.9/100,000 children per
year
More common in boys than girls
AIS ETIOLOGY AND RISK FACTORS
Older adults:
Hypertension
Smoking
Diabetes
Hypercholesterolemia
AIS ETIOLOGIES AND RISK FACTORS
Children:
Cardiac abnormalities
Vascular lesions
Genetic conditions
Hematologic abnormalities (such as sickle
cell disease)
Infection
AIS ETIOLOGIES AND RISK FACTORS
Young adults:
Vasculopathy (such as arterial dissection)
Recent pregnancy and other
hypercoagulable states
Smoking, drug use
Premature atherosclerosis
Hypertension
Possibly migraine
INTERNATIONAL PEDIATRIC
STROKE STUDY (2010)
Multi-center
report
>600 children (age 29 days to 18 years)
with AIS
Most frequent conditions:
Arteriopathy (53%)
Cardiac disorders (31%)
Infection (24%)
AIS RISK FACTORS
Cardiac
Abnormalities:
Congenital heart disease is a risk factor
for cardioembolic stroke
Acquired cardiac lesions such as
endocarditis, cardiomyopathy, and
prosthetic valve placement
AIS RISK FACTORS
Hematologic
abnormalities
Sickle cell disease
~300 times higher than that seen in
children without SCD
Other inherited or acquired prothrombotic
disorders such as:
Anemia (particularly iron deficiency)
Antiphospholipid syndrome
Factor V Leiden mutation
AIS RISK FACTORS
Vasculopathy
Abnormalities
of the cerebral vasculature
Inherited or acquired
Pediatric
Stroke Study :
525 children (ages 29 days to 19 years)
with arterial ischemic stroke
Vascular imaging found arteriopathy in
277 (53%)
In the 277 cases with arteriopathy:
Focal cerebral arteriopathy of childhood
(25%)
Primary or secondary moyamoya (22%)
Dissection (20%)
Vasculitis (12%)
Sickle cell disease arteriopathy (8%)
Postvaricella arteriopathy (7%)
Miscellaneous types (4%)
Unspecified (3%)
FOCAL CEREBRAL ARTERIOPATHY (FCA)
OF CHILDHOOD
Term
used by the International Pediatric
Stroke Study
Unexplained focal arterial stenosis in a
child with arterial ischemic stroke
FOCAL CEREBRAL ARTERIOPATHY (FCA)
OF CHILDHOOD
Etiology
unknown, probably multifactorial
Possible causes:
Inflammation and vasculitis due to
infection (eg antecedent varicella
infection) or autoimmune disease
Thromboembolic arterial occlusion or
stenosis
Intracranial dissection
Arterial spasm
Prothrombotic factors
MOYAMOYA SYNDROME
Progressive
stenosis of the internal
carotid arteries and formation of collateral
vessels
Name moyamoya means “puff of smoke”
in Japanese and describes the look of the
tangle of tiny vessels formed to
compensate for the blockage
ARTERIAL DISSECTION
Definite
or probable trauma is identified
in some cases
Spontaneous dissection also occurs
Connective tissue disorders such as
vascular Ehlers- Danlos syndrome and
Marfan syndrome can predispose to
dissection
VASCULITIS
Inflammatory
changes in the cerebral
vessels
Primary
Kawasaki disease
Secondary
Collagen vascular diseases (such as
Lupus)
Infections (bacterial meningitis, viral
infections)
OTHER ABNORMITIES OF VESSEL
STRUCTURE
Arterial
tortuosity syndrome
Vasospasms
resulting from subarachnoid
hemorrhage
Fibromuscular
dysplasia
METABOLIC DISORDERS
Several
metabolic conditions associated
with arterial ischemic stroke
Generally through effects on the vessel
wall
CADASIL
MELAS
CADASIL
Cerebral
Autosomal-Dominant
Arteriopathy with Subcortical Infarcts
and Leukoencephalopathy
Mutation in the Notch3 gene, short arm of
chromosome 19
Progressive degeneration of smooth
muscle cells in the vessel wall
May present with migraine, TIA, or
ischemic stroke in late childhood or early
adulthood
MELAS
Mitochondrial
Encephalopathy with Lactic
Acidosis and Stroke-like episodes
Mutations of mitochondrial DNA
Metabolic stroke rather arterial stroke
Occurrence of stroke-like episodes: temporary
muscle weakness on one side of the body
(hemiparesis)
Other features: focal or generalized seizures,
recurrent migraine-like headaches, vomiting,
short stature, hearing loss and muscle
weakness, dementia
MELAS
Diagnostic
criteria:
Stroke-like episodes
Encephalopathy characterized by seizures
or dementia
Blood lactic acidosis or
Presence of ragged red fibers in skeletal
muscle biopsy
INGESTION
Cocaine
and methamphetamine
Can stroke due to hypertension,
vasospasm, or vasculitis
CLINICAL PRESENTATION
Infants
with stroke:
Seizures, altered mental status, or focal
weakness
Children
with stroke:
Hemiparesis or other focal neurologic
signs such as aphasia, visual disturbance,
or cerebellar signs
Although seizures, headache and lethargy
are not uncommon
IF NOT A STROKE, WHAT COULD IT BE?
Broad
differential diagnosis
Extended in young children because
stroke may present with nonspecific signs
such as seizures or lethargy
Vascular
abnormalities can present much
like AIS:
Intracranial hemorrhage
Aneurysms
Arteriovenous malformation
Cerebral venous thrombosis
NONVASCULAR CONDITIONS THAT MIMIC
STROKE IN CHILDREN:
Tumors and other structural brain lesions
Prolonged postictal paresis (Todd’s)
Complicated migraine
Familial alternating hemiplegia
Posterior reversible encephalopathy syndrome (PRES)
Metabolic stroke
Intracranial infection (brain abscess or
meningoencephalitis)
Demyelinating conditions (ADEM)
Idiopathic intracranial hypertension
Drug toxicity
Post infectious cerebellitis
Psychogenic conditions
WHAT NEUROIMAGING?
Neuroimaging
in children with suspected
stroke:
Brain MRI
Head CT can be substituted of MRI is not
tolerated or will not be available within 48
hours
Also consider MRA head and neck to evaluate arteries
Axial T1 MRI neck to evaluate for
dissection
WHAT LABS?
EKG,
ECHO, O2 saturation
Laboratory studies:
CBC, BMP, glucose, pt, ptt,
Toxicology, blood alcohol, pregnancy test
Hypercoagulable evaluation
Vasculitis evaluation (angiography, ESR,
CRP, ANA, varicella titers, HIV, RPR)
MELAS suspected, lactate level from
serum and CSF, molecular genetic testing,
muscle biopsy
CAN WE GIVE TPA?
Initial
treatment of children with acute
arterial ischemic stroke :
Recombinant
tissue plasminogen activator
(tPA) is NOT approved in the United
States by the FDA for the use in children
<18 years of age with ischemic stroke
The
effectiveness, safety and dose of tPA
for the treatment of children with arterial
ischemic stroke have not been established
Consensus
guidelines recommend NOT
using thrombolysis or mechanical
thrombectomy outside the of specific
research protocols or clinical trails
Initial
antithrombotic treatment:
No
randomized controlled trials
examining the effectiveness of antiplatelet
or anticoagulation therapy
Limited
data suggests that
anticoagualtion therapy in children has
an acceptable safety profile, although
efficacy remains uncertain
WHAT IS THE TREATMENT?
Ischemic
stroke of unknown etiology:
Aspirin 3 to 5mg/kg per day rather than
anticoagulation as initial therapy
High
clinical suspicion for either
dissection or cardioembolism:
Short-term anticoagulation with LMWH
or unfractionated heparin until vascular
imaging and echocardiography are
obtained
Anticoagulation
should be stopped and
aspirin initiated if no indication (eg, a
confirmed cardioemboilc source or arterial
dissection)
Confirmed
cardioemboilc source, arterial
dissection, or hypercoagulable state:
Initial
anticoagulation treatment (rather
than aspirin)
IV unfractionated heparin (goal ptt 60-85) or
subcutaneous LMWH (eg, enoxaparin) for 5-7
days
Followed by treatment with LMWH or
warfarin
Aspirin (3 to 5mg/kg day) should be given if
there is a contraindication to anticoagulation
AIS
Resulting from sickle cell disease:
Urgent intravenous hydration
Urgent exchange transfusion (goal
hemoglobin S fraction <30% of total
hemoglobin)
IF IT IS A STROKE, WHAT IS THE
PROGNOSIS?
Prognosis:
In
hospital mortality after ischemic stroke
in children ages 1 to 17 years – 3.4%
Disability:
Despite neural plasticity,
majority have persistent disability
WILL IT REOCCUR?
Recurrent
ischemia, including stroke and
TIA:
Common after childhood arterial ischemic
stroke
Recurrence ranging from 6.6 to 20%
Presence of vasculopathy may be an
important risk factor for recurrent stroke
in children with later childhood stroke
Cohort
study with cerebrovascualr
imaging available for 52 children with
later childhood stroke
5-year stroke recurrence rate for children
with abnormal vascular imaging was 66%
While children with normal vascular
imaging had no recurrences
CONCLUSION
Childhood
arterial ischemic stroke differs
from adult stroke in risk factors,
etiologies, and outcomes
Secondary stroke prevention with
antiplatelets or anticoagulation are
adapted from adult stroke management
Little is known about the safety and
efficacy of acute thrombolytic therapy in
various age groups
Further
study is greatly needed for a
better understanding of the pathogenesis,
management, and outcomes in childhood
arterial ischemic stroke
REFERENCES
Roach ES,Golomb MR, Adams R, et al. Management of stroke in infants
and children: a scientific statement from a Special Writing Group of the
American Heart Association Stroke Council and the Council on
Cardiovascular disease in the Young. Stroke 2008; 39:26644.
Monagle, P, Chan AK, Golenberg NA, et al. Antithrombotic therapy in
neonates and children; Antithrombotic Therapy and Prevention of
Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based
Clinical Preactice Guidleline. Chest 2012; 141:e737S.
Pediatric Stroke Working Group. Stroke in childhood: Clinicial guidelines
for diagnosis, management and rehabilitation. November 2004.
www.rcplondon.ac.uk/pubs/books/chidstroke (accessed on January 14,
2011).
Smith, S, Ischemic stroke in children: Ischemic stroke in children and
young adult: Etiology and clinical features. In: UpToDate: 2012.
Smith, S, Ischemic stroke in children: Evaluation, initial management,
and prognosis. In: UpToDate: 2012.